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Delayed hemolytic transfusion reactions (DHTRs) are generally at- 
tributed to an anamnestic immune response. Case reports of DHTRs 
due to a primary immune response are rare. Transfusion reactions 
occurring in patients on the pediatric burn unit from 1981 to 
September 1988 were reviewed, and additional information was 
obtained for patients for whom a DHTR was documented. Of 62 
transfusion reactions, 11 were classified as a primary immune response 
(DHTR), with either a positive antibody screen, a positive direct 
antiglobulin test (DAT), or both. None of the 11 patients included 
in the study had been previously tranfused or pregnant. The average 
number of units transfused prior to antibody identification was 19. 
The average time elapsed between the first transfusion and antibody 
identification was 3.6 weeks. Anti-K and anti-E were the most fre- 
quently identified. Three patients had a decrease in hemoglobin 
(average 1.5 g/dL) and hematocrit at the time that a positive DAT 
was detected. Such changes could not be demonstrated for the re- 
maining eight patients. The conclusion was that a DHTR may he 
caused by a primary immune response in burned children more 
often than expected, but DHTR signs and symptoms are 
often not apparent due to the complications of burn trauma. 
Immunohematology 1991;1:8-11. 
Blood tranfusion with an expected rise in hematocrit 
usually precedes the appearance of a delayed hemolytic 
transfusion reaction (DHTR). Three to 14 days after the 
transfusion there is a decrease in hematocrit, and other 
laboratory and clinical findings may develop, including 
fever, jaundice, hemoglobinuria, spherocytes on the 
peripheral smear, and a positive direct antiglobulin test 
(DAT). The DAT may remain positive until all incom- 
patible transfused red cells have been cleared from the 
circulation. The responsible antibody should then be 
detectable in the patient’s serum or eluate and will re- 
main detectable in the serum from weeks to years.sup(1,2,3,4) 
The diagnosis of a DHTR is often missed if clinical 
symptoms are mild or absent. One researcher reported 
that among 40 cases of DHTRs encountered over a 
5-year period, there were 34 in which a positive DAT 
was the first clue to correct diagnosis. In the remain- 
ing six cases, the first indication of a DHTR was a 
positive indirect antiglobulin test (IAT), the presence 
of spherocytes in the blood film, or an unexpected 
decrease in hemoglobin concentration.sup(5) 
In studies conducted at the Mayo Clinic from 1978- 
1980, DHTRs were reported at the rate of one per 1,500 
transfusions.sup(6) The Mayo Clinic investigators proposed 
the following criteria for the diagnosis of a DHTR: 
(1) the pretransfusion crossmatch was compatible at all 
phases; (2) the pretransfusion antibody screen of the 
recipient’s serum was negative; (3) a repeat crossmatch 
of donor cells with posttranfusion recipient serum was 
incompatible; (4) DAT and IAT on the posttransfusion 
recipient sample were positive; (5) antibody could be 
eluted from the recipient’s red cells after transfusion; 
(6)  history of pregnancy or transfusion was available; 
(7) at least two of the following clinical and laboratory 
tests suggestive of hemolysis were present: elevated levels 
of serum indirect bilirubin, decreased blood hemoglobin 
level by 1 g/dL or more, decreased serum haptoglobin 
level by 50 percent or more from pretransfusion level, 
hemoglobinuria, or hemosiderinuria. 
DHTRs are generally attributed to an anamnestic im- 
mune response and only rarely result from a primary 
immune response.sup(1,2,3,4) One case of a DHTR caused 
by a primary immune response was reported by Pat- 
ten et al.sup(7) The patient had received blood after com- 
plications of a vaginal delivery and presented with 
hemoglobinuria and anemia (hemoglobin 8.0 g/dL) 4 
weeks posttransfusion. The causative antibody, anti- 
c, could not be identified for another 4 weeks. The 
length of time before the antibody could be identified 
and the patient’s history of no prior transfusion or 
pregnancy led to the assumption that this DHTR was 
due to a primary immune response. 
Another case of a DHTR caused by a primary immune 
response was reported by Solanki and McCurdy.sup(8) The 
17-year-old sickle cell disease patient had not been 
tranfused previously. He received two units of red cells, 
which resulted in the expected rise in hemoglobin and 
hematocrit. Between 9 and 12 days later the hematocrit 
value dropped to the pretransfusion level. The blood 
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bank was unable to demonstrate a positive DAT or the 
existence of an antibody. The anemia was then treated 
with an additional transfusion, which resulted in an 
anamnestic-like response. Symptoms included fever, 
hemoglobinemia, hemoglobinuria, and transient renal 
failure. Anti-C, -E, -Jksup(b), and -Fysup(a) were eluted from his 
red cells 24 hours after the acute reaction. Included 
in the report were two other cases of DHTRs occur- 
ring in patients with a negative transfusion history. A 
38-year-old female developed a reaction 10-15 days after 
an initial transfusion of two units of red cells. Three 
days later, anti-E and -Wr sup(a) were identified. A 48 year- 
old nontransfused female developed an anti-M and -H 
9-12 days after transfusion of two units. Pregnancy 
history was not given in either case. 
We decided to study patients in our hospital to deter- 
mine whether a primary immune response could be 
documented and whether it was responsible for DHTRs. 
A chart review was done on pediatric burn patients. 
This population was chosen because the group con- 
sisted of previously healthy children who had no history 
of prior transfusions or pregnancy As burn patients, 
these children were multiply transfused, could be 
followed in the hospital for weeks, and frequently 
developed red cell alloantibodies. 
Materials and Methods 
Regardless of type, all transfusion reactions from 1981 
to September 1988 in patients on the pediatric burn 
unit were reviewed and then sorted according to 
etiology Sixty-two suspected transfusion reactions had 
been reported and evaluated by the blood bank pro- 
tocol (consisting of a DAT, inspection of the serum for 
icterus or hemolysis, and clerical check). Eight reac- 
tions were not considered to meet criteria and therefore 
were not classified. There were 11 DHTRs, 25 febrile 
reactions, 17 allergic reactions, and one case of an ABO 
incompatible plasma transfusion. The diagnosis of 
DHTR was based on serological evidence only. When 
a recently transfused patient demonstrated a new anti- 
body and/or the DAT was positive, a transfusion reac- 
tion report was generated and categorized as a DHTR. 
If possible, the donor unit segments were typed for the 
corresponding antigen. Only the reactions classified 
as DHTR were included for chart review. The data col- 
lected included age, sex, degree and percent of burn, 
ABO and Rh type, identity of the antibodies found in 
the serum or eluate, results of the DAT, the time inter- 
val between the first transfusion and antibody detec- 
tion, prior medical history, and whether the reaction 
was detected by the primary care physician or by the 
laboratory during routine pretransfusion testing. Clinical 
and laboratory symptoms of DHTR such as fever, unex- 
plained fall in hemoglobin or hematocrit, hemo- 
globinemia, and hemoglobinuria were also particularly 
noted. 
Antibody identifications and elutions were performed 
by standard blood bank procedures. 
Results 
All 11 DHTRs due to primary immune response had 
been detected in the blood bank during routine 
pretransfusion testing. All had a negative DM and LAT 
before transfusion. The DATs became positive in 8 of 
the patients, but the antibody screen became positive 
in all 11 (Table 1). The average time interval between 
the first transfusion ,and antibody detection was 3.6 
weeks (range 10 days to 16 weeks). The average number 
of units transfused until antibody detection was 19 (range 
10-57). AU patients were Rh positive-five As, four Os, 
and two Bs. Caucasian, black, and Hispanic persons 
were represented. Ages ranged from 22 months to 18 
years. 
The most frequently identifed antibodies were anti-E 
and -K. Three patients had anti-E and -K in their serum, 
but each had only one or the other in the eluate. Other 
antibodies identified were anti-C, -S, and -Jksup(a), all oc- 
curring singly. In all but cases #1, 3, and 4, the cor- 
responding antigens were found on the red cells of some 
of the units transfused. Those three cases received 28, 
39, and 38 units, respectively, and antigen exposure 
could be inferred from the expected frequency of the 
antigen in the donor population. Clinical symptoms 
and laboratory parameters indicative of DHTR were dif- 
ficult to demonstrate because of the nature of burn 
trauma. These patients were febrile most of the time, 
and many were suffering from multiple bacterial in- 
fections. Although daily hematological parameters were 
available, many could not be correlated to the DHTR, 
because the patients had had repeated surgeries for skin 
grafts ,and/or orthopedic repair. No serum haptoglobin 
results were found on the charts. Liver enzymes, 
bilirubin, and coagulation studies were not done 
routinely. 
Extensive family and medical history had been ob- 
tained on each patient. None of these 11 patients had 
prior transfusion documented on their charts, nor was 
there anything in their histories that made prior transfu- 
sion suspect. Two females, ages 16 and 18, denied a 
history of pregnancy. 
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Table 1. Serological and clinical findings in children with a primary immune response 
Number of units 
transfused prior 
to detection of Time Anti- Direct -anti Laboratory 
case # Age/sex antibody interval' body globulin test? Eluate data 
Hgb,Hct s
1 10/F 28 4.0 E,K m+,IgG,poly K 
2 2/M 16 2.3 E,K m+,poly E 
3 10/M 30 16.0 K m+lgG,poly K Hgh,Hct 
4 16/F 38 4.0 K neg not done * 
5 14/M 57 8.0 s m+,poly,C3,IgG neg 
6 18/F 14 1.9 C m +  ,IgG,poly C 
7 13/M 26 11.0 Jksup(a) m+,poly,C3 neg 
8 13/M 38 9.0 E M+ ,IgG E 
9 2/M 10 2.1 E,K m+,C3 pos/too weak 
10 7/F 13 2.4 E 
11 22 mo./F 12 1.4 E ,neg I to identify neg not done 
Average 19 3.6 
'Weeks between transfusion and antibody detection. Transfusions in other hospitals before transfer to this institution were included. 
†Microscopic reaction (m+) 
Positive with polyspecific antihuman globulin (poly) 
Positive with monoclonal anti-IgG antihuman globulin (IsG) 
Positive with anticomplement fraction in antihuman globulin (C3) 
constant febrile state. 
‡Unable to correlate clinical symptoms such as anemia (decrease in hemoglobin, hematocrit, fever. etc.), because of surgery on that day or 
Three patients had a decrease in hemoglobin and 
hematocrit close to the time that the blood bank 
reported a positive DAT. The primary care physician 
did not suspect a DHTR in any of the 3 patients. In 
case #1, the patient was found to have a positive DAT 
2 days after his hemoglobin decreased from 11.0 g/dL 
to 9.8 g/dL. There was no surgery or documented 
bleeding that would have explained the decrease, and 
the hemoglobin had been stable for several days before 
the decrease. In case #2, the patient's hemoglobin 
decreased from 10.7 g/dL to 9.0 g/dL on the day that 
the blood bank reported a positive DAT. No apparent 
cause for the decrease was documented on the chart. 
Case #3 had a decrease in hemoglobin from 13.3 g/dL 
to 12.5 g/dL on the day that the positive DAT was 
reported, and it continued to decrease to 11.7 g/dL the 
next day. This patient's last surgery and transfusion had 
been three months before the discovery of the antibody 
The average decrease in hemoglobin for these three 
patients was 1.5 g/dL. 
Only case #5 had experienced several febrile reac- 
tions probably due to leukoagglutinins before the 
development of the red cell alloantibody. 
Discussion 
The accepted time frame for an anamnestic response 
ranges from 2-14 days but usually occurs within 7 
days.sup(4,9,10) Antibody production due to a primary 
response, on the other hand, occurs no earlier than 7-10 
days and may not be detectable for several weeks.sup(4,9,11) 
Absence of prior red cell exposure and the average time 
interval of 3.6 weeks (range 10 days to 4 months) from 
the first transfusion until the antibody detection lead 
to the conclusion that the antibodies detected in our 
patients were probably due to a primary immune 
response. The mild or absent clinical symptoms are also 
compatible with this conclusion. Unfortunately, the 
severity of the patients' injuries made clinical symp- 
toms difficult to relate to their blood transfusions. 
The frequency with which anti-E and -K were im- 
plicated should be expected on the basis of the an- 
tigenicity of the Rh and Kell antigens.sup(4) Several studies 
have shown anti-Jksup(a) to be the most commonly found 
antibody in DHTR due to an anamnestic immune 
response,sup(3,4,6) because most Kidd antibodies become 
undetectable a few weeks or months after stimulation. 
The only Kidd antibody found in our study was not 
detected until 11 weeks after the initial transfusion, a 
length of time that would not he indicative of an 
anamnestic response. 
These children were atypical in that their immune 
systems had been hyperstimulated by such factors as 
trauma, bacterial infections, skin grafts, and multiple 
transfusions. With the exception of the 18-year-old 
female who developed an anti-C in 13 days, the fastest 
antibody producers were the youngest patients in our 
population. The 22-month-old produced anti-E in 10 
days, and two 2-year-olds produced anti-K and -E in 
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16 and 15 days, respectively. Further study is indicated 
to demonstrate whether burned children become sen- 
sitized to red cell antigens more frequently than other 
pediatric patients or adults. 
At least one author believes that documentation of 
nonsymptomatic DHTRs is unnecessary.sup(3) Many of these 
nonsymptomatic DHTRs are probably due to a primary 
immune response. Therefore, detection and identification 
of red cell alloantibodies as soon as possible after in- 
itial transfusion would be the best means of avoiding 
anamnestic DHTRs in the future. 
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